Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 475

Results For "EU"

5150 News Found

Lonza to expand its drug manufacturing network in Switzerland
Biotech | September 23, 2021

Lonza to expand its drug manufacturing network in Switzerland

Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland


UFlex joins Alliance in its mission to end plastic waste
Sustainability | September 23, 2021

UFlex joins Alliance in its mission to end plastic waste

UFlex has committed close to US $ 10 million towards various initiatives at its overseas and Indian plants to repurpose plastic waste


Endimension receives Rs 2.3 crore in seed funding
Startup | September 23, 2021

Endimension receives Rs 2.3 crore in seed funding

The startup’s AI platform uses AI algorithms to automatically detect abnormalities and diseases in medical images, reducing patient misdiagnosis and increasing radiologists’ productivity


Indian Pharma Market growth stable in August 2021
News | September 23, 2021

Indian Pharma Market growth stable in August 2021

Post normalisation of high growth months of April and May this year the average IPM growth from June to August this year stood at 15.2 % YoY : Ind-Ra reports


Boehringer Ingelheim acquires Abexxa Biologics to advance its cancer research
Biotech | September 22, 2021

Boehringer Ingelheim acquires Abexxa Biologics to advance its cancer research

The addition of Abexxa’s expertise complements Boehringer Ingelheim’s current approaches to the treatment of difficult-to-treat solid cancers and especially those resistant to available immunotherapies


SCHOTT expands tubing capacity in India
Packaging | September 22, 2021

SCHOTT expands tubing capacity in India

In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT


DCGI approves Ampio Pharma’s Phase II trials to tackle Covid-19 induced respiratory distress
Biotech | September 22, 2021

DCGI approves Ampio Pharma’s Phase II trials to tackle Covid-19 induced respiratory distress

Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs


Pfizer and BioNTech’s Covid-19 vaccine safe for children aged 5 to 11: study
Biotech | September 21, 2021

Pfizer and BioNTech’s Covid-19 vaccine safe for children aged 5 to 11: study

In participants 5 to 11 years of age, the vaccine was safe, well-tolerated and showed robust neutralising antibody responses. Results in children under 5 years of age are expected as soon as later this year


Lincoln Pharma plans to launch Cephalosporin product portfolio soon
Drug Approval | September 21, 2021

Lincoln Pharma plans to launch Cephalosporin product portfolio soon

Cephalosporin is a bactericidal, broad-spectrum, and P-lactam antibiotic originally derived from the fungus Acremonium, which is used to treat bacterial infections such as pneumonia, skin infections, ear infection, strep throat, staph infections, tonsillitis, bronchitis among others


U.S. FDA approves Samsung Bioepis and Biogen’s BYOOVIZ biosimilar
Drug Approval | September 21, 2021

U.S. FDA approves Samsung Bioepis and Biogen’s BYOOVIZ biosimilar

It becomes the first ophthalmology biosimilar to gain FDA approval in the United States